Related references
Note: Only part of the references are listed.A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response
George Sflomos et al.
CANCER CELL (2016)
Prognostic significance of inflammatory factors expression by stroma from breast carcinomas
Belen Fernandez-Garcia et al.
CARCINOGENESIS (2016)
Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype
Sanket H. Shah et al.
CANCER BIOLOGY & THERAPY (2015)
The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells
Hai Wang et al.
CANCER CELL (2015)
Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment
Donna M. Sosnoski et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche
Michelle A. Lawson et al.
NATURE COMMUNICATIONS (2015)
Modeling Selective Elimination of Quiescent Cancer Cells from Bone Marrow
Stephen P. Cavnar et al.
NEOPLASIA (2015)
Osteoblastic niche supports the growth of quiescent multiple myeloma cells
Zheng Chen et al.
BLOOD (2014)
Molecular characterization of exosome-like vesicles from breast cancer cells
Stefan Kruger et al.
BMC CANCER (2014)
CDCP1 Identifies a CD146 Negative Subset of Marrow Fibroblasts Involved with Cytokine Production
Mineo Iwata et al.
PLOS ONE (2014)
Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells
Makiko Ono et al.
SCIENCE SIGNALING (2014)
Functionally and Phenotypically Distinct Subpopulations of Marrow Stromal Cells Are Fibroblast in Origin and Induce Different Fates in Peripheral Blood Monocytes
Mineo Iwata et al.
STEM CELLS AND DEVELOPMENT (2014)
Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways
Lisly Chery et al.
ONCOTARGET (2014)
Importance of exosome depletion protocols to eliminate functional and RNA-containing extracellular vesicles from fetal bovine serum
Ganesh Vilas Shelke et al.
JOURNAL OF EXTRACELLULAR VESICLES (2014)
Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy
Wen Zhou et al.
NATURE REVIEWS CANCER (2014)
Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells
Ndiya Ogba et al.
BREAST CANCER RESEARCH (2014)
A Novel Model of Dormancy for Bone Metastatic Breast Cancer Cells
Rebecca Marlow et al.
CANCER RESEARCH (2013)
Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma
Xiang H. -F. Zhang et al.
CELL (2013)
Hormonally responsive breast cancer cells in a microfluidic co-culture model as a sensor of microenvironmental activity
Jessica D. Lang et al.
INTEGRATIVE BIOLOGY (2013)
A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences
Lorenza Mittempergher et al.
MOLECULAR ONCOLOGY (2013)
BMP/Coco antagonism as a deterministic factor of metastasis dormancy in lung
Jarrod Martinez et al.
BREAST CANCER RESEARCH (2013)
Prognostic Value of Estrogen Receptor α and Progesterone Receptor Conversion in Distant Breast Cancer Metastases
Laurien D. C. Hoefnagel et al.
CANCER (2012)
The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites
Hua Gao et al.
CELL (2012)
Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer
Nathan R. West et al.
ENDOCRINE-RELATED CANCER (2012)
miRNAs and estrogen action
Carolyn M. Klinge
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis
Robin Fuchs-Young et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual Disease
Maria Soledad Sosa et al.
CLINICAL CANCER RESEARCH (2011)
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
Yusuke Shiozawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
Aya Kobayashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer
Xin Pan et al.
NATURE MEDICINE (2011)
Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence
Lyndsay V. Rhodes et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Why not treat human cancer with interleukin-1 blockade?
Charles A. Dinarello
CANCER AND METASTASIS REVIEWS (2010)
Vascular Endothelial Growth Factor Secreted by Activated Stroma Enhances Angiogenesis and Hormone-Independent Growth of Estrogen Receptor-Positive Breast Cancer
Mauricio P. Pinto et al.
CANCER RESEARCH (2010)
Development and characterization of a conditionally immortalized human fetal osteoblastic cell line
Steven A. Harris et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Receptor conversion in distant breast cancer metastases
Laurien D. C. Hoefnagel et al.
BREAST CANCER RESEARCH (2010)
Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation
Mina Takahashi et al.
JOURNAL OF ENDOCRINOLOGY (2008)
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
Tanja Fehm et al.
BREAST CANCER RESEARCH (2008)
The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-α
Archana Dhasarathy et al.
MOLECULAR ENDOCRINOLOGY (2007)
Epigenetic modulation of estrogen receptor-α by pRb family proteins:: A novel mechanism in breast cancer
Marcella Macaluso et al.
CANCER RESEARCH (2007)
Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment
Anne M. Lewis et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
IL-1β-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IκB-ξ
Jack B. Cowland et al.
JOURNAL OF IMMUNOLOGY (2006)
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis
S Svensson et al.
ONCOGENE (2005)
Molecular and cellular determinants of estrogen receptor α expression
JJ Pinzone et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
IL-1 is required for tumor invasiveness and angiogenesis
E Voronov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-α and essential for the anti proliferative activity of ICI 182,780 in ERα-positive breast cancer cells
MY Fan et al.
MOLECULAR ENDOCRINOLOGY (2003)
Increased proteasome-dependent degradation of estrogen receptor-alpha by TGF-beta 1 in breast cancer cell lines
TA Petrel et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Interleukin-1 alpha promotes tumor growth and cachexia in MCF-7 xenograft model of breast cancer
S Kumar et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Mechanism of 17-β-estradiol-induced Erk1/2 activation in breast cancer cells
VG Keshamouni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of estrogen receptor-α gene expression by epidermal growth factor
A Stoica et al.
JOURNAL OF ENDOCRINOLOGY (2000)
Share Paper
